Author

Ann Strydom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 3 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:statistical model· 3 Research Focus:benchmarking· 2 Assay:DNA methylation· 2 Research Focus:variant calling· 2 Assay:whole-genome sequencing· 2 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Nazneen RahmaniD· 4 shared Angela George· 3 shared Elise RuarkiD· 2 shared Helen Hanson· 2 shared Ingrid Slade· 2 shared Shazia Mahamdallie· 2 shared Sheila Seal· 2 shared Victoria Cloke· 2 shared

Activity by Year

2015-2016 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetics

Nazneen RahmanORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A discrete event simulation to evaluate the cost effectiveness of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer

Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman

This study evaluates the cost-effectiveness of germline BRCA testing in UK ovarian cancer patients, finding it cost-effective with an ICER of £4,339/QALY.

bioRxiv · Jun 24, 2016 · PreprintGenetics

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore, Ann Strydom, Susana Banerjee, Helen Hanson, Nazneen Rahman, Mainstreaming Cancer Genetics (MCG) Programme

This study implements a streamlined BRCA gene testing pathway for ovarian cancer patients, achieving high uptake and efficiency with significant cost savings and improved patient outcomes.

bioRxiv · Mar 16, 2016Genetics

A cost analysis of a cancer genetic service model in the UK

Ingrid Slade, Helen Hanson, Angela George, Kelly Kohut, Ann Strydom, Sarah Wordsworth, Nazneen Rahman, MCG Programme

This paper analyzes the costs of BRCA gene testing pathways in a UK cancer genetics service, finding significant cost variation and suggesting cost-efficiency improvements by testing more cancer patients.

Journal of Community Genetics · Feb 27, 2016Peer-reviewedGenetics

CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinic

Márton Münz, Elise Ruark, Anthony Renwick, Emma Ramsay, Matthew Clarke, Shazia Mahamdallie, Victoria Cloke, Sheila Seal, Ann Strydom, Gerton Lunter, Nazneen Rahman

This paper introduces CSN and CAVA, tools for standardized, rapid variant annotation of NGS data, showing high accuracy and clinical relevance in BRCA1/BRCA2 analysis.

bioRxiv · Mar 21, 2015Genomics